Medtronic plc — Director's Dealing 2019

Jul 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-07-29

Reporting Person: COYLE MICHAEL J (EVP & Group Pres, Cardiac&Vasc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-29	Ordinary Shares	A	14850	—	Acquired	217708	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-29	Stock Option (Right to Buy)	$103.26	A	99045	Acquired	2029-07-29	Ordinary Shares (99045)	Direct
2019-07-29	Stock Option (Right to Buy)	$103.26	A	1615	Acquired	2029-07-29	Ordinary Shares (1615)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	250	Indirect
Ordinary Shares	4104	Indirect

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.

F2: This balance increased by 2,157 shares due to exempt transactions such as dividend reinvestment.

F3: The number of shares beneficially owned includes 521 ordinary shares that were inadvertently omitted from Mr. Coyle's previous filings. The previously omitted shares were issued upon the conversion of 545 ordinary shares of Covidien plc that were held by Mr. Coyle at the time of the acquisition by Medtronic plc in January 2015.

F4: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.